MENLO PARK, Calif. — Healthier Capital has closed its inaugural venture fund at $220 million, exceeding its initial target as investor interest grows in technology-driven healthcare innovation.
The health-tech venture capital firm said Fund 1 was oversubscribed and includes backing from universities, endowments, family offices, healthcare organizations, and other institutional investors. The fund will focus on early-stage companies working at the intersection of healthcare and technology, with an emphasis on artificial intelligence and modernized health information systems.
Healthier Capital was founded by Amir Dan Rubin, former chief executive officer of One Medical and a former senior executive at Optum and UnitedHealth Group. Rubin previously led One Medical through its 2020 public offering and its acquisition by Amazon in 2023.
“At Healthier Capital, we are focused on delivering healthier outcomes for all, partnering with technology-powered innovators to deliver transformative impact and significant value creation,” Rubin said.
The firm’s leadership team includes healthcare executives, clinicians, researchers, and investors with experience across health systems, payers, startups, and consulting firms. Partners have held leadership roles at organizations including CVS Health, Aetna, UPMC, UCLA Health, and McKinsey & Company.
Healthier Capital said it works closely with portfolio companies by drawing on its network of health systems, payers, policymakers, and academic institutions to help accelerate growth and operational execution.
Several portfolio companies have already gained national recognition. One portfolio company has been acquired, while three others were named to the CB Insights Digital Health 50 list for 2025. Two companies were also finalists in the 2025 Fierce Healthcare Innovation Awards.
Healthier Capital’s investments span a range of healthcare sectors, including conversational AI, clinical analytics, preventive imaging, oncology care, mental health, genomics, and pediatric care. Portfolio companies include Hyro, which develops conversational AI tools for healthcare organizations; Qualified Health, which offers a platform for deploying and governing generative AI in healthcare settings; and Ezra, an AI-based imaging company acquired in 2025 by Function Health.
Other investments include companies focused on oncology care coordination, mental health services, genomics analytics, behavioral health platforms, and technology-enabled pediatric care delivery.
Industry leaders working with Healthier Capital cited the firm’s operational experience as a differentiator in supporting healthcare-focused startups as they scale.
Healthier Capital said Fund 1 positions the firm to continue investing in companies aimed at improving clinical outcomes, operational efficiency, and access to care as healthcare organizations increasingly adopt AI and digital technologies.
